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the impact of volatile organic chemicals on themolecular organization of the skin barrier lipids. Themodels built
upon previously developed self-assembled lipid membranes which have composition and 3D organization
similar to those of the lipidmatrix in SC. In onemodel the target chemicals were incorporated in the lipids before
their self-assembly, and in the other one theywere applied on top of a preformed lipidmembrane. The chemicals
could be incorporated within the model membranes in quantities close to those reached within human SC upon
heavy surface loading. The dose-dependent effects of the chemicals on the lateral molecular organization in the
models were qualitatively identical to those observed by infrared spectroscopy in human SC. The models
facilitated the interpretation of X-ray diffraction proﬁles used to determine the nature of the interactions
between the chemicals and the lipid lamellae and the position of the exogenous molecules within the unit cell
of the lipid phases. These model systems are suitable for in vitro studies in the areas of skin biophysics,
dermatology, transdermal drug delivery, and risk assessment.
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The lack of a reliable experimental strategy—one combining an
appropriate substrate and sound methodology—can be a serious
bottleneck in evaluating the impact of exogenous chemicals on the
biophysical and physicochemical properties of the human skin barrier.
Such investigations are essential for the successful design of safe topical
products (e.g., cosmetics, transdermal drugs, and insect repellents) and
for understanding—and thereby, ﬁnding ways to counteract—the
damages caused by hazardous chemicals, environmental pollutants,
and chemical warfare agents to the topmost skin layers. Here, we
demonstrate the use of synthetic lipid membranes to investigate the
inﬂuence of volatile organic compounds on the molecular organization
of the skin barrier lipids. The impact of the chemicals on the lateral
packing and conformational order of the lipid chains in the synthetic
membranes observed by Fourier transform infrared spectroscopyyl 1,4-cyclohexanedicarboxylate;
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ights reserved.(FTIR) was qualitatively identical to the one observed in native human
stratum corneum (SC). Small-angle X-ray diffraction (SAXD) studies
showed that the chemicals can swell the lamellar lipid phases and
pointed to their localization within the lipid lamellae.
Themolecular organization of the extracellular lipids in the topmost
skin layer, SC, is crucial for maintaining an efﬁcient barrier to the
evaporation of water from the viable skin tissues and to the skin
penetration of exogenous molecules [1–7]. Most of the experimental
evidence collected so far indicates that these lipids—comprising mainly
ceramides, free fatty acids, and cholesterol in approximately equimolar
proportions [8–10]—are arranged in extended lamellar sheets with two
characteristic periodicities: one of around 13 nm (denoted as long
periodicity phase, LPP) and one of around 6 nm (denoted as short
periodicity phase, SPP) [11–14]. The lateral packing of the hydrocarbon
lipid chains in these lamellae is predominantly orthorhombic (OR),with
a small fraction of the lipids forming hexagonal (HEX) and liquid-
crystalline (LIQ) phases [15–18]. The presence of lamellar structures of
appropriate periodicity and containing high relative fractions of OR-
packed lipids is essential for the low permeability of SC [19–21].
Chemicals that come into contact with the skin and are capable of
admixing with the native SC lipids can, in principle, modify their
molecular organization and, thereby, alter the permeability of the SC.
Reliable measurement and quantiﬁcation of these effects is essential
for understanding skin homeostasis.
The combination of FTIR and SAXD is ideally suited to investigate the
lateral and the lamellar organization in structured lipid ensembles [11].
Its application to study the effects of topically applied chemicals on SC
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of an appropriate substrate. Excised human skin is not readily available
in sufﬁcient quantities and is prone to considerable inter- and intra-
individual variability in the molecular organization of the SC lipids
[22–24]. Its replacement by animal (e.g., porcine) skin in studies of the
SC lipid biophysics is not possible because of signiﬁcant inter-species
differences [17,25]. Finally, the interpretation of FTIR spectra collected
from SC is not always straightforward because of the overlap of
spectroscopic signals originating from the SC proteins and lipids [16,26].
The stratum corneum substitute (SCS) is a previously developed
synthetic model of the SC extracellular lipids [27]. Its composition,
although simpliﬁed, comprises the main lipid classes and relevant
subclasses found in the SC lipidmatrix, and its 3Dmolecular organization
is similar to the one of the SC lipids [28]. The preparation of the model is
simple and fast; it consists in mixing the synthetic lipids in the desired
proportions, depositing the mixture on an appropriate substrate,
equilibrating it at elevated temperature, and letting the lipids self-
assemble while slowly cooling down the sample [29]. Because of its
similarity to the SC lipid matrix structure, reproducible preparation,
and the possibility to control precisely its composition, the SCS has
emerged as a suitable alternative for human skin in ranking the skin
permeation of topically applied chemicals [30] and in studying the
molecular organization of healthy, diseased, and treated SC [31–33].
In this work, we examined the suitability of the SCS as a surrogate for
human SC in studying the interactions between SC lipids and volatile,
lipophilic, organic molecules, a class of chemicals that frequently contact
the skin due to their broad use as fragrance raw materials (FRMs),
solvents, drug penetration enhancers, and cosmeceuticals. As model
compoundswe used three FRMs—γ-undecalactone (UL), dodecyl acetate
(DA), and diethyl 1,4-cyclohexanedicarboxylate (CC)—chosen to have
different combinations of lipophilicity (asmeasured by their log P values)
and chemical functionality, and a medium volatility. We formulated two
model systems based on the SCS which differed in their preparation: in
one (denoted as mixSCS), the FRMs were admixed with the synthetic
lipids before their self-assembly; in the other (denoted as topSCS), the
FRMs were applied topically to the surface of a preformed SCS. To
evaluate if the two models reproduce correctly the impact of the
chemicals on the lipid organization in human SC, as a reference we
used excised human skin treated topically with the same FRMs.
First, we examined the FRM content that could be reached in the two
SCS models and in the SC of excised skin. At the end of the application
period, we removed the surface excesses of FRMs and quantiﬁed
the amounts of FRMs contained within the lipid lamellae by gas
chromatographic analysis of dissolved topSCS and mixSCS samples
and of 30 tape-strips applied to the excised skin samples. Next, we
investigated the mixing of the FRMs with the synthetic and native SC
lipids and their effect on the conformational order and the lateral
organization within the lipid lamellae using FTIR spectroscopy. We
collected transmission FTIR spectra from the mixSCS and topSCS
samples and ATR-FTIR spectra at progressively greater depths within
the SC during tape-stripping of the skin samples. To enable concurrent
observation of the spectroscopic signals originating from the FRMs
and the lipids, we used samples prepared as described above but treated
with perdeuterated analogs of the FRMs (denoted as dFRM). Finally, we
investigated the effects of the FRMs on the presence and the repeat
distances of the LPP and the SPP, and the electron density distribution
within the LPP in mixSCS and topSCS using SAXD.
2. Materials and methods
2.1. FRMs
UL, DA, and CC (Table 1) were supplied by Firmenich SA (Geneva,
Switzerland), and their perdeuterated analogs (denoted as dUL, dDA,
and dCC, respectively) were synthesized as described in Supplementary
material.2.2. Composition of the lipid and FRM–lipid mixtures
First, we prepared separatemixtures of ceramides and fatty acids. The
ceramide mixture comprised (EOS)C30, (NS)C24, (NP)C24, and (NP)C16
(all from Cosmoferm B.V., Delft, The Netherlands) in a molar ratio of
16:56:18:10; in these acronyms of the ceramide structure, N and EO
denote the type of fatty acyl chain (non-hydroxy or ω-hydroxy ester-
linked to a linoleic acid, respectively), S and P denote the type of
sphingoid base (sphingosine or phytosphingosine, respectively, both
containing 18 carbon atoms), and Cxx indicates the number of carbon
atoms in the fatty acyl chain. The fatty acid mixture comprised palmitic,
stearic, arachidic, behenic, tricosanoic, lignoceric, and cerotic acid from
Sigma-Aldrich Chemie GmbH (Schnelldorf, Germany) in a molar ratio of
1.8:4.0:7.7:42.6:5.2:34.7:4.1. The proportions of the individual ceramides
and fatty acids were selected to mimic as closely as possible those found
in human SC with the available synthetic molecules [34–37]. Next, we
combined appropriate amounts of the ceramide mixture, cholesterol
(from Sigma-Aldrich Chemie GmbH, Schnelldorf, Germany), and the
fatty acidmixture to result in an equimolar ratio of the three lipid classes,
and transferred them to hexane:ethanol (2:1, v/v) with a total lipid
concentration of 4.5 mg/mL. For preparation of mixSCS, we diluted the
FRMs 10 times with hexane:ethanol (2:1, v/v) and added an appropriate
volume of these solutions to the lipid solution to obtain FRM:lipid molar
ratios of 1.67 and 3.33.
2.3. Preparation of SCS and mixSCS
We sprayed the lipid and FRM–lipid solutions on the substrates (CaF2
windows fromSpecac, Kent, UK andNuclepore polycarbonate ﬁlter disks
with a pore size of 50nm fromWhatman, Kent, UK) using a Linomat IV
(Camag, Muttenz, Switzerland; for details, see Supplementary material).
After spraying, we placed the samples covered with a glass chamber
on a hotplate and equilibrated them at 78 ± 1 °C (temperature at the
sample surface) for 10 min. (For SCS samples prepared for bench-top
SAXD measurements, we used a slightly modiﬁed protocol: ﬁrst, we
equilibrated the SCS samples at 90 ± 1 °C for 1 min, and then within
10min reduced the temperature to 78±1°C.) Preliminary experiments
showed that the mixSCS samples suffered considerable losses of FRMs
during spraying and the high-temperature equilibration procedure
(data not shown). To minimize these losses, we performed the
equilibration step in a saturated FRMgas environment created by placing
25μL of the corresponding FRMs in a vial inside the glass chamber. After
the high-temperature equilibration, we let the self-assembly of the lipid
lamellae proceed while slowly cooling down the samples to room
temperature (approximately 30–50 min). After their preparation, we
rinsed the surface of mixSCS samples with 0.6 mL ethanol to remove
any FRMs thatmay have adsorbed to the surface during the equilibration
in saturated FRM atmosphere (see also Section 2.5).
2.4. Treatment of excised skin and topSCS with FRMs
We used abdominal skin from Caucasian female subjects aged 45 to
53, dermatomed to a nominal thickness of 579±20μm (Bioprédic Intl.,
Rennes, France), and stored at−20°C. Before use, we trimmed the skin
to circles with a diameter of 20mm, thawed each piece on absorbing
paper, and cleaned the SC surface with three cotton swabs soaked
with cold hexane, to remove traces of sebum. Before treatment, we
placed a piece of skin (SC side up) on a static Franz diffusion cell ﬁlled
with PBS buffer (150mM, pH7.4) containing 1% Tween-20 which was
thermostated at 37 °C, and let it equilibrate for 30min. We delimited a
test area of 0.95 cm2 on top of the skin using a PTFE spacer with a
circular hole (d = 1.1 cm) in the middle. To treat the skin with the
FRMs, we used dFRM formulated as simpliﬁed Eau de Toilette (EdT)
solutions [30% (w/w) dFRM in ethanol:water (9:1, v/v)]. We applied
3 μL EdT on the skin surface using a 5-μL-Hamilton syringe, and evenly
spread the liquid over the test area; thus, the resulting dose delivered
Table 1
Fragrance raw materials (FRMs) used in this study.
Fragrance material CAS no. Structure Molecular weight log P Vapor pressure
[Pa]
γ-Undecalactone (UL) 000104-67-6 184.28 3.06 0.55
Dodecyl acetate (DA) 000112-66-3 228.37 5.78 1.61
Diethyl 1,4-cyclohexanedicarboxylate (CC)a 072903-27-6 228.28 3.09 1.68
a The cis/trans ratio in protonated CC was equal to 80/20, and in perdeuterated CC—to 67/33.
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the FRMs, we let their interactions with SC proceed for 4 h. We
performed all experiments using skin from three to ﬁve different
donors.
We applied the FRMs to the surface of topSCS pure or formulated as
model EdT solutions of concentrations varying between 6 and 50%
(w/w) using either the Linomat instrument or the 5-μL-Hamilton
syringe. Following the deposition of the FRMs, we let their interactions
with the topSCS proceed for 6 or 16 h. At the end of this period, we
rinsed the sample surface using the procedure employed with mixSCS.
Using dFRM, we established that the volume of ethanol we used for
the rinse is sufﬁcient to remove any FRMs that may have remained at
the sample surface at the end of the application period (data not
shown).
2.5. Quantiﬁcation of the FRM content in SC and SCS
Four hours after the application of EdT, we wiped the skin surface
with three cotton swabs, to remove any FRMs remaining on the skin
surface, and tape-stripped the SC 30 times using D-Squame tapes
(CuDerm, Dallas, USA) as described elsewhere [38]. To quantify the
amounts of FRMs within the SC, we extracted the 2nd to the 30th
tapes (the ﬁrst four pooled together, and the rest—in groups of ﬁve)
by one-hour sonication in 1.5 mL iso-octane, and quantiﬁed the FRM
concentrations in the extract by gas chromatography (GC/FID; for
more details, see Supplementary material). As recommended in the
regulatory guidelines [39], we did not take into account the FRM
amounts found on the ﬁrst tape since theymight comprise also residual
molecules from the SC surface. To establish the depth proﬁles of the
FRM contents, we estimated the depth within SC reached by removing
each tape-strip as previously described [40].
To account for the different lipid content within the SC and SCS, we
expressed both the amounts of FRMs that we applied to the sample
surface and those that we found within the lipid lamellae as the molar
ratios of FRMs and lipids within the sample volume [further denoted
as (FRM:L)applied and (FRM:L)found].
To calculate (FRM:L)applied for the two SCS models, we employed the
nominal amounts of FRMs and lipids used for sample preparation, and
to calculate (FRM:L)found—the amounts of FRMs and lipids found in the
samples at the end of their preparation and rinsing. We dissolved the
samples in 1 or 2mL hexane:ethanol (2:1, v/v) and quantiﬁed the FRMs
in the solution by GC/FID. In mixSCS samples, we quantiﬁed the FRM
content immediately after performing FTIR or SAXD measurements.
Since the FTIR measurements on topSCS samples took a long time, for
experimental convenience we determined the FRM content not after
the measurements but in samples prepared in parallel using the exact
same procedures; to save the valuable perdeuterated FRMs, we prepared
these samples using protonated FRMs. To estimate correctly the lipid
amounts in the samples, we took into account the lipid losses resulting
from the ethanol rinse. For untreated SCS and topSCS samples, we
quantiﬁed the losses by comparing the integrated absorbances of the
νs(CH2) bands in spectra collected before and after rinsing. Depending
on the FRM type and content, the average losses measured over the
whole area of topSCS samples varied between 5.7 and 23.3% (the valuesmeasured on individual spots of diameter 100–200 μm varied between
1 and 30%). For mixSCS samples, we estimated the lipid losses to be
equal to those measured in untreated SCS samples, i.e., 17.4%.
To estimate (FRM:L)applied and (FRM:L)found for SC, we made two
assumptions: (i) that the amounts of FRMs that have penetrated within
the lipid lamellae can be approximated by those that were recovered
with the 2nd to 30th stripping tapes (an assumption supported by the
depth proﬁles of the FRM content within the SC, see Fig. S1 in
Supplementary material); (ii) that the molar content of lipids in the
volume of SC delimited by the application area of 0.95 cm2 can be
estimated assuming a uniform SC thickness of 15μmand a lipid content
within SC of 20% (w/w) [40].We chose to use these assumptions instead
of isolating thewhole SC and quantifying its exact FRM content to avoid
losses of the volatile FRMs during the heat separation of the SC.Weused
the lipid and FRM content of the SC layers reached by strippingwith the
ﬁrst ﬁve tapes to estimate also the (FRM:L)found in the upper SC layers.2.6. FTIR
2.6.1. SC
We collected ATR–FTIR spectra from the SC sides of the skin samples
(at least three different samples treated with each FRM) before and
after stripping with 1, 3, 5, 10, 15, 20 and 30 tapes. To determine the
depth within SC at which the spectra were collected we used the
previously established procedure described in [40]. For more details,
see Supplementary material.2.6.2. MixSCS and topSCS
We collected transmission FTIR spectra from four to seven different
spots of two or three samples for each composition. For mixSCS, the
spots were circular with diameters of 100 or 200 μm, and for topSCS
they were squares with dimensions of 170 × 170 μm. We collected
spectra from mixSCS immediately after preparation and rinsing, and
from topSCS—6 or 16 h after the application of dFRM (to determine
the effect of FRMs on the conformational order and the lateral packing
of the lipid alkyl chains) and once again after rinsing the surface
(to determine the mixing of FRMs with lipids). For more details, see
Supplementary material.2.6.3. Data treatment
We used the software OPUS 5.5 from Bruker (Germany). To
determine the peak positions of the νs(CH2) and νs(CD2) bands we
used a center of gravity algorithm applied at 95% of the peak height,
after baseline-correcting the spectra between the endpoints of the
νs(CH2) and νs(CD2) regions (for SC samples) or an algorithm based
on the minima in second-derivative spectra (for SCS samples); the
choice of these algorithms was based on the different shapes of the
baselines and the different signal-to-noise ratios in spectra collected
from the two substrates. To calculate the width of δ(CH2) at 50% of the
peak height in second-derivative spectra (denoted as FWHMscis), we
used the procedure described in detail in [17].
Table 2
FRM loading and content in SC, mixSCS, and topSCS. The amounts of FRMs are shown as
the molar ratios of FRMs and lipids within the sample volumes. See text for details.
FRM System FRM:Lapplieda Application
time [h]
FRM:Lfoundb
UL SC 6.7 4 upper SCc: 0.93± 0.40
whole SCd: 0.19±0.06
mixSCS 1.67 – 0.37±0.06
topSCS 7.27±0.42
7.27±0.42
6
16
0.27±0.08
0.52±0.04
DA SC 5.33 4 upper SCc: 0.43± 0.31
whole SCd: 0.16±0.05
mixSCS 1.67 – 0.14±0.05
topSCS 0.60±0.02
5.35±0.30
6
16
0.11±0.02
0.97±0.06
CC SC 5.51 4 upper SCc: 1.14± 0.51
whole SCd: 0.25±0.08
mixSCS 1.67 – 0.20±0.02
topSCS 6.22±0.90
13.79±0.08
16
16
0.15±0.02
0.15±0.02
a Normalized amount of FRMs used for sample preparation.
b Normalized amount of FRMs found in the samples.
c Normalized amount of FRMs found in the SC layers removed by tapes 2 to 5.
d Normalized amount of FRMs found in the SC layers removed by tapes 2 to 30.
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We collected X-ray diffraction patterns from themixSCS and topSCS
samples (two samples for each composition) in a bench-top diffrac-
tometer D5000 from Siemens (Germany) for 1 or 2 h at room
temperature. For topSCS, we collected diffraction patterns before and
after the treatment of the same sample with FRMs. We collected also
high-quality diffraction patterns from untreated SCS and topSCS
containing CC using the beam line BM26B at the European Synchrotron
Radiation Facility, ESRF (Grenoble, France). We collected diffraction
patterns from two samples of each composition for 5 min at room
temperature. For more details, see Supplementary material.
2.7.1. Data treatment
To compare diffraction patterns collected from the different samples
we used one-dimensional plots of the scattering intensity I versus the
scattering vector q calculated as q = (4πsinθ)/λ (see Ref. [41] for the
transformation of the two-dimensional synchrotron SAXD patterns into
one-dimensional patterns). To facilitate the comparison, we baseline-
corrected the bench-top diffraction patterns using the software OPUS
5.5 from Bruker (Germany) and a rubber-band function; subsequently,
we normalized them to identical integrated areas of the sum of the 2nd
and 3rd diffraction orders of the LPP, the 1st diffraction order of the
SPP, and the 1st diffraction order of crystalline cholesterol, as these
peaks were present in all samples. We calculated the repeat distance of
the lamellar phases d from the positions of series of equidistant peaks
(qn) using d=2nπ/qn, where n is the order of the diffraction peak. We
could use only the positions of the 2nd, 3rd and sometimes 4th
diffraction orders of the LPP as the low signal-to-noise ratio precluded
reliable detection of the higher orders. (Even though the partial overlap
between the 2nd order of the LPP and the 1st order of the SPP made
the determination of the peak position less accurate, we estimated that
this uncertainty was not bigger than the one introduced by the
broadness of the other diffraction peaks.) We calculated the electron
density distribution within the LPP in untreated SCS and topSCS
containing CC using the diffraction orders 1–6 of the LPP in diffraction
patterns collected in the synchrotron as previously described [41,42].
3. Results and discussion
3.1. Content of FRMs in SC, mixSCS, and topSCS
To be a useful substitute for human skin in studies of the molecular
interactions between topically applied chemicals and the SC lipids, a
model system has to (i) incorporate these chemicals in quantities
comparable to those that can be reached within the lipid matrix of
human SC, and (ii) reﬂect faithfully their effects on the molecular
organization of the SC lipids. Thus, we ﬁrst compared the FRM content
within the two SCS models with the one reached within SC following
fairly heavy loading of the skin surface with FRMs (corresponding to
application of approximately 3 μmoles of FRM per cm2). The FRM
doses that we used were many-fold higher than those found in real-
life applications of fragrances, to facilitate the detection of the resulting
effects and to estimate the upper limit of skin loading that can be
reproduced in the two SCS models.
To enable this comparison despite the different lipid contents of SC
and SCS, we expressed both the amounts of FRMs that we used in the
sample preparation and those that we found within the lipid lamellae
as themolar ratios of FRMs and lipidswithin the sample volume [further
denoted as (FRM:L)applied and (FRM:L)found; see Materials and methods
for details of the calculation].
Table 2 summarizes the experimental results obtained in the three
systems. As expected, the FRM contentwithin the SC gradually decreased
from the surface to the inner layers (see also Fig. S1). Accordingly, the
(FRM:L)found estimated for the upper layers of SC (i.e., those removed
by stripping with tapes 2 to 5) were higher than those averaged overthe whole SC thickness, and the magnitude of the difference depended
on the shape of the FRM gradient.
In mixSCS we reached (FRM:L)found similar to those observed within
the whole SC thickness; the (FRM:L)applied that we were able to use,
however, was three to four-fold lower than those we applied on skin.
In samples prepared with (FRM:L)applied ≥ 3.33 (i.e., a value almost
two-fold lower than the one used on SC), we observed macroscopic
liquid domains, indicating that the FRMs had phase-separated and
could not be incorporated within the lipid lamellae during their self-
assembly.
In topSCS we also obtained (FRM:L)found similar to or higher than
those observed within the whole SC thickness. We were able to
modulate the UL and DA contents in the samples by varying the surface
loading and the duration of the application period. Interestingly, we
found identical relative amounts of CC in samples prepared using
(CC:L)applied ratios that differed by a factor of two.
In summary, the amounts of FRMs that we could incorporate within
mixSCS and topSCS models were similar to those we found within the
SC following fairly heavy loading of the skin surface. TopSCS, however,
was able to support a broader range of (FRM:L)applied than mixSCS.
3.2. Mixing of UL and DA with lipids in SC, mixSCS, and topSCS
FTIR spectroscopy of samples prepared with perdeuterated analogs
of the FRMs allowed us to evaluate the degree of mixing between FRM
and lipid molecules [43,44]. The position of the methylene symmetric
stretching peak νs(CH2) is diagnostic for the degree of conformational
order in alkyl chains: it shifts to lower wavenumbers when the
conformational order of the chains increases. Such relative ordering of
the alkyl chains of UL andDA in respect to their conformation in solution
is expected to occur if theymixwith the structured lipids in the lamellae
of SC and SCS. Since the νs(CH2) band (originating from the lipids) and
the νs(CD2) band (originating from the FRMs) appear in different and
well-separated spectral regions, we could analyze simultaneously the
degree of conformational ordering of the deuterated alkyl chains of UL
and DA and of the protonated alkyl chains of the lipids. The presence
of only two methylene groups in the side chains of CC precluded such
analysis of samples treated with this FRMs as the intensity of the
νs(CD2) band was too low to determine precisely its peak position.
Fig. 1 shows the shift in the positions of the νs(CD2) peaks
originating from dUL and dDA relative to their position in solution
upon interaction of the FRMs with the lipids of SC, mixSCS, and topSCS.
The νs(CD2) bands of the two FRMs shifted to lowerwavenumbers in all
Fig. 1. Conformational ordering of the alkyl chains of UL and DA uponmixing with SC and
SCS lipids. Shift of the position of νs(CD2) bands originating from dUL (left panel) and dDA
(right panel) in SC,mixSCS, and topSCS relative to their position in solution. For SC, the data
points (n=10) represent values measured at different depths within the SC in the course
of tape-stripping of three to six different skin samples for each FRM. For mixSCS, the data
points (n=6 for dUL and n=8 for dDA) represent valuesmeasured in samples containing
(FRM:L)found equal to 0.37 ± 0.06 and 0.14 ± 0.05 for dUL and dDA, respectively. For
topSCS, the data points (n = 4 for dUL and n = 7 for dDA) represent values measured
after rinsing the surface of two or three samples containing (FRM:L)found equal to
0.27 ± 0.08 for dUL and 0.11 ± 0.02 for dDA. The bars represent the average values of
the shift.
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with the lipid molecules and thereby became more ordered than in
solution. The shifts observed for dDA were larger than those observed
for dUL in the same systems, indicating that the conformational disorder
of the alkyl chains of ULwas higher than the one of DA,most probably as
a consequence of the bulkier head group and shorter length of the alkyl
chains of UL compared to those of DA.
In summary, these results show that the alkyl chains of the FRMs
incorporate in the lipid lamellae and mix with the lipid alkyl chains
both in the SC and in the two synthetic models.
3.3. Effect of FRMs on the conformational order and the lateral packing of
the lipid alkyl chains
To compare the effects that the FRMs exerted on the conformational
ordering and the lateral packing of the lipid alkyl chains in SC and in the
two syntheticmodels,we used twodiagnostic spectroscopic parameters:
the position of the νs(CH2) peak as a measure for the average
conformational ordering of the lipid chains, and the width of the
methylene scissoring band δ(CH2) (further denoted as FWHMscis) as a
measure for the relative content of OR lipid phases.
Fig. 2A and B shows representative examples of the depth variations
of these two parameters observed in untreated SC and in SC treated
with the three dFRMmolecules. In qualitative agreement with previous
reports [16,45,46], the position of the νs(CH2) peak in untreated SC
shifted to higher wavenumbers within the SC (from approximately
2847 cm−1 at the SC surface to 2851 cm−1 in the inner SC layers)
indicating a gradual increase of the conformational disorder of the
lipid chains (Fig. 2A). The incorporation of the dFRM within the SC led
to a signiﬁcant shift of the position of νs(CH2) peak to higher
wavenumbers in the topmost 1.5–2 μm of the SC indicating that the
molecules induced conformational disorder of the SC lipid chains. The
observed shift correlated well with the depth proﬁles of the FRM
contents in the SC (see Fig. S1): it was highest at the SC surface and
gradually decreased with the SC depth.
None of the three FRMs inﬂuenced signiﬁcantly the depth proﬁle of
FWHMscis compared to the one observed in untreated SC (Fig. 2B). In
both untreated and treatedwith FRMSC samples, the values of FWHMscis
remained stable at around 11–12 cm−1 throughout most of theexamined SC thickness, indicating that a large fraction of the SC lipids
participated in OR lattices. The decrease of FWHMscis in the innermost
SC layers, typical for native SC, was not inﬂuenced by the presence of
FRMs. Apparently, neither the extent nor the depth distribution of OR
phases within the SC was perturbed by the presence of FRMs.
Next, we investigated these spectroscopic parameters in the two
synthetic models. In SCS samples prepared in the absence of FRMs,
both the position of the νs(CH2) peak (2849.3 ± 0.1 cm−1) and the
FWHMscis (12.6±0.1 cm−1) were close to those observed in untreated
human SC and indicated that the alkyl chains in the SCS were
conformationally ordered and packed predominantly in OR phases.
(The difference of approximately 2 cm−1 in the positions of the
νs(CH2) peaks in SCS and in the surface layers of human SC reﬂects
the well-known red-shifting of absorbance bands in spectra of bulk
materials collected in ATR mode compared to their positions in
transmission spectra [47].) The two spectroscopic parameters remained
unchanged in mixSCS containing all three FRMs (Fig. 2C and D),
indicating that the conformational order and lateral packing of the lipids
had not changed upon inclusion of the FRMs in the lipid lamellae. This
lack of effect is not surprising, considering that the FRM content in the
mixSCS samples was more than two-fold lower than the one in the
topmost 1.5–2 μm of the SC which caused conformational disorder of
the lipids. Upon application of three-fold lower amounts of FRMs to
the skin surface, the conformation and the lateral packing of the SC
lipids also remained unchanged (data not shown); clearly, the effects
of the chemicals on the lipid organization were dose-dependent.
Fig. 2E summarizes the changes that the incorporation of the FRMs
caused to the position of the νs(CH2) peak relative to those observed
in the same spots of topSCS samples before application of the FRMs.
These changes were qualitatively identical to the ones observed in SC.
For all three FRMsweobserved a shift of the position of νs(CH2) towards
higher wavenumbers indicating an increase of the conformational
disorder of the lipid alkyl chains. For dUL and dDA, the magnitude of
the shift increased with the FRM content of the layers. Not surprisingly,
while having the same sign, the absolute magnitude of the shifts
observed in topSCS was lower than those observed in SC. Since the
FTIR spectra of topSCS were collected in transmission mode, they
contained information averaged throughout the full thickness of the
samples; thus, the magnitude of any spectral shifts that may have
occurred in the FRM-rich topmost layers of the samples was lowered
by signal originating from the inner layers of the topSCS samples which
contained little if any FRMs. In contrast, by applying tape-stripping and
ATR–FTIR spectroscopy to the skin samples we obtained spectroscopic
information from thin layers of the SC, with thickness determined by
the effective pathlength of the IR radiation in our setup (estimated
from the Harrick's equation [47] to be equal to approximately 2.3 μm at
2850 cm−1 assuming a homogeneous incident angle of the IR beam
equal to 45° and a refractive index of the SC equal to 1.5); thus, we
could evidence the local perturbations that have occurred within the
lipid lamellae of the topmost SC layers without averaging the
spectroscopic information throughout the full SC thickness.
In topSCS samples with (FRM:L)found similar to those in SC, we
observed the same lack of effect of the FRMs on FWHMscis as in SC
(Fig. 2F). The values of FWHMscis remained identical to those in
untreated SCS and dropped by an average of 1.75 cm−1 only for dDA
when its average content in the layers reached (FRM:L)found= 0.97±
0.06, a value two-fold higher than the dDA content within the topmost
SC layers in which it had no effect on FWHMscis. As discussed above, the
values of (FRM:L)found reﬂect the average content of the FRMs
throughout the topSCS thickness; thus, it is highly probable that the
differences of the lateral lipid packing observed in the two systems
were due to the many-fold higher local content of dDA in the upper
layers of topSCS compared to the one in the topmost SC layers.
In summary, both mixSCS and topSCS reproduced qualitatively the
existence and the dose-dependence of the effects that the FRMs caused
on the conformational order and lateral packing of the lipids in SC.
Fig. 2. Inﬂuence of FRMs on the conformational order and the lateral organization of the lipids in human SC (A, B), mixSCS (C, D), and topSCS (E, F). (A, B) Typical depth proﬁles of the
position of the νs(CH2) peak (A) and the FWHMscis (B) in spectra collected from untreated SC and following application of dFRM. The symbols represent the values of the two parameters
in spectra collected in the course of tape-stripping of the SC; the connecting lines are for guidance of the eye only. Data from skin of one donor. The values of (FRM:L) found within the upper
SC layers (i.e., those removed by the ﬁrst ﬁve tapes) were equal to 0.93±0.40, 0.43±0.31, and 1.14±0.51 for dUL, dDA, and dCC, respectively. (C–F) Shift in the position of the νs(CH2)
peak (C, E) and change of FWHMscis (D, F) in spectra collected frommixSCS (C, D) and topSCS (E, F) relative to those in spectra collected from untreated SCS. In the mixSCS samples, the
values of (FRM:L)found were equal to 0.37±0.06, 0.14±0.05, and 0.20±0.02 for dUL, dDA, and dCC, respectively. In the topSCS samples, the values of (FRM:L)found for dUL were equal to
0.27±0.08 and 0.52±0.04 (shown respectively as circles and triangles), for dDAwere equal to 0.11±0.02 and 0.97±0.06 (shown respectively as circles and triangles), and for dCCwere
equal to 0.15±0.02. Each data point corresponds to the value observed in a spectrum collected from one spot of the sample. The bars represent the average value of the shift.
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In addition to the effects of the FRMs on the lateral lipid organization,
using SAXD of mixSCS and topSCS we could also assess how the FRMs
inﬂuence three important parameters of the lamellar lipid organization:
the presence of LPP and SPP, the repeat distance of the LPP, and the
density distribution within the unit cell of the LPP. Fig. 3 shows typical
diffraction patterns collected from untreated SCS, mixSCS and topSCS
using a bench-top diffractometer. In agreement with earlier reports
[11,27], the patterns of untreated SCS displayed peaks associated with
the LPP (located at approximately 1.1, 1.6, and 2.1nm−1), SPP (located
at approximately 1.2 and 2.4nm−1), and crystalline cholesterol (located
at approximately 1.9 nm−1); the corresponding repeat distances
calculated for the LPP and SPP were equal to 11.8 nm (Fig. 4A) and
5.3 nm, respectively. In the patterns collected from mixSCS (Fig. 3A),the positions of the peaks associated with the LPP were shifted to
lower q-values, indicating the swelling of this phase; the repeat
distances calculated for LPP in mixSCS containing UL, DA, and CC were
4, 3, and 2% higher than those observed in untreated SCS (Fig. 4B). The
position and the corresponding repeat distance of the SPP in these
layers remained unchanged. The presence of the FRMs during the self-
assembly of the lipid lamellae affected to a different extent the relative
content of the two lipid phases, as estimated from the relative
contributions of the peaks associated with the two phases to the
normalized patterns shown in Fig. 3A: while in mixSCS containing UL
the ratio of LPP/SPP was similar to the one observed in untreated SCS,
in mixSCS containing DA and CC it was noticeably higher than in
untreated SCS.
The diffraction patterns collected from topSCS also contained peaks
associated with LPP, SPP, and crystalline cholesterol (Fig. 3B). The
Fig. 3. Lamellar organization in untreated, mixSCS, and topSCS. Typical diffraction patterns
collected from untreated SCS and mixSCS (A) and untreated SCS and topSCS (B). The
numbers on top of the patterns indicate the (FRM:L)found in the samples. Arabic (2 to 4)
and Roman (I) numbers mark the orders of the diffraction peaks of LPP and SPP,
respectively, and an asterisk — the 1st order of diffraction of crystalline cholesterol. The
vertical dotted lines indicate these peak positions in samples of untreated SCS.
Fig. 4.Repeat distance of the LPP calculated for untreated SCS (A),mixSCSwith (FRM:L)found
equal to 0.37±0.06, 0.14±0.05, and 0.20±0.02 for UL, DA, and CC, respectively (B), and
topSCS with (FRM:L)found equal to 0.27 ± 0.08, 0.11 ± 0.02, and 0.15 ± 0.02 for UL, DA,
and CC, respectively (C). Each data point represents a repeat distance calculated from one
of the diffraction orders of the LPP in patterns collected from two different samples for
each composition. The bars show the average repeat distance calculated for each SCS.
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the LPP were shifted to even lower q-values than those in mixSCS,
indicating that the topical application of FRMs increased the repeat
distance of the LPP even further. The repeat distances calculated for
topSCS containing UL, DA, and CC were 7, 9, and 6% higher than those
calculated for untreated SCS (Fig. 4C); for UL, this swelling of the LPP
was independent of the FRM content in the layers, as evidenced by
the identical positions of the peaks associated with the LPP in patterns
collected from samples of different (FRM:L)found values. Similarly to
mixSCS, the position of the peaks associated with the SPP remained
unchanged compared to those observed in untreated SCS. In the
patterns collected from topSCS treated with UL and DA we observed a
dose-dependent decrease of the content of lamellar phases: the overall
signal-to-noise ratio in the normalized patterns of topSCS treated with
UL decreased considerably with increasing the FRM content in the
lamellae (Fig. 3B), and samples of topSCS containing relatively high
amounts of DA [(FRM:L)found = 0.97± 0.06] produced no measurable
patterns (data not shown).
The swelling of the LPP observed in both mixSCS and topSCS, the
unchanged repeat distance of the SPP, and the dose-dependence of
the content of LPP indicate that the FRMs interacted predominantly
with (and inserted into) the LPP and only a little (if at all) with the
SPP. The data in Figs. 3 and 4, however, give no indication if the
distribution of the FRMs within the unit cell of the LPP was
homogeneous or if the FRM molecules were located at a particular
portion of the unit cell. Because of the high contrast that perdeuterated
molecules give in the diffraction pattern, neutron diffraction studies
would be, in principle, ideally suited to address this question [48].
Unfortunately, the density proﬁle of the scattering length in LPP is not
known; in our experience, obtaining it is not a trivial task. Since water
molecules are present not only at the borders but also within the unit
cell of the LPP, the identiﬁcation of the phase signs is not straightforward
and goes well beyond the scope of the present work. SAXD analysis
however, provides a useful alternative to calculate the distribution of
the FRM molecules since the electron density proﬁle of the LPP has
been previously established [42]. The distribution of the FRMmolecules
can be obtained by calculating the electron density distribution within
the unit cell of LPP using high-resolution diffraction patterns (i.e., ones
with considerably higher signal-to-noise ratio than the patterns
collected using a bench-top diffractometer shown in Fig. 3) and an
appropriately chosen set of phase signs [14,42,49]. As a demonstration
of principle, we probed the position of CC from the distribution of the
electron density of the LPP in patterns collected using a synchrotron
from untreated SCS and topSCS (see Fig. S2), as the swelling of the LPP
in this model was considerably higher than the one observed inmixSCS.
We used the set of phase signs (− + + − − +) that we determined
earlier from structure factor amplitudes calculated for untreated SCS of
eight different compositions [42]. The structure factor amplitudes
calculated with this set of phase signs for untreated SCS and topSCS
containing CC ﬁt well to the Fourier curve associated with LPP that we
determined in [42]; the high quality of the ﬁt (R2 values of 0.916 and
0.951) validated our choice of the phase solution.
Fig. 5 compares the electron density distribution within the LPP in
untreated SCS and topSCS containing CC. Both curves displayed four
main regions of high electron density positioned around ±6 and
±2 nm from the center of the unit cell. Earlier, we have ascribed these
peaks to the location of ceramide headgroupswithin the trilayer structure
in the unit cell of the LPP [14,42]. While the overall pattern of the density
distribution in topSCS was similar to the one in untreated SCS, the
positions of the high density regions observed in the two samples,
however, differed signiﬁcantly: the spacing between the peaks of high
density was equal to 4.5, 2.8 and 4.5 nm in untreated SCS (resulting in a
unit cell of 11.8 nm) and to 4.5, 3.8, and 4.5 nm in topSCS (resulting in a
unit cell of 12.8 nm). Apparently, the swelling of the LPP caused by
incorporation of CC in topSCS was limited only to the central region of
the LPP, thus suggesting (predominant) localization of CC within this
Fig. 5. Distribution of the electron density around the center of the unit cell of LPP
(positioned at 0 nm) in untreated SCS (thin line) and topSCS containing CC with (FRM:
L)found equal to 0.15 ± 0.02 (thick line). The thin and thick dashed lines indicate the
boundaries of the unit cells in untreated SCS and in topSCS containing CC, respectively.
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organization of LPP which postulates a central region containing
relatively disordered alkyl chains sandwiched between two peripheral
regions containing crystalline alkyl chains [11]. Thus, it is not surprising
to ﬁnd the CC molecules accommodated within the less dense central
region without interfering with the OR-packed lipids in the peripheral
regions; our data on the unchanged OR packing upon insertion of CC
(see Fig. 2) further support this hypothesis.
4. Conclusions
In this work, we investigated the possibility to reproduce the
interactions between volatile organic chemicals and the SC barrier lipids
in two synthetic lipid models. Our results show that it is possible to
incorporate these chemicals within the lipid lamellae of the models in
quantities comparable to those reached within the SC of excised
human skin. Both the existence and the dose-dependence of the effects
that these molecules exerted on the lateral organization of the SC lipids
could be qualitatively reproduced in the SCS. The SCS models also
facilitated the investigation of the lamellar organization of the barrier
lipids by SAXD which is considerably more difﬁcult using SC isolated
from excised skin [50,51]; thus, we could elucidate the nature of the
interaction between the chemicals and the lipid lamellae (disruption
or non-perturbing insertion) and the position of the exogenous
molecules within the unit cell of the LPP.
When comparing the suitability of the two SCS models to study the
effects of topically applied chemicals, topSCS emerged as more
appropriate than mixSCS. In it, the chemicals were applied on top of
preformed lipid lamellae of appropriate 3D structure, and—contrary to
the situation in mixSCS—did not interfere with the self-assembly of
the lipids. Furthermore, the FRM distribution within topSCS was most
probably inhomogeneous with a content gradually decreasing with
depth, similar to the gradients observed in SC and unlike the expected
homogeneous FRM distribution within mixSCS. Finally, topSCS was
able to support a broader range of (FRM:L)applied than mixSCS and
can, therefore, be used in more extensive dose–response studies.
Nonetheless, it is important to keep inmind that the structure of topSCS
is considerably more labile than the one of native SC in which the
stability of the lipid lamellae is greatly enhanced by the presence of
corneocytes.
One practical limitation that the SCSmodels imposed on the studies
of skin–fragrance interactions is that they did not allow determination
of the depth proﬁles of FRM contents and lateral lipid organization
which we could achieve in SC by combining tape-stripping with
GC and ATR–FTIR. Regarding the molecular organization of the lipid
lamellae, however, it should be possible to collect spectra from
increasingly thicker layers of the SCS lamellae using ATR–FTIR
spectroscopy with variable angle of incidence [52], and thus follow therelative changes of different spectroscopic parameters within the SCS
thickness. The SCS models have one important advantage over SC in
spectroscopic studies: they offer the possibility to investigate the
hydrogen bonding between the head groups of the barrier lipids
following the spectroscopic changes in the amide regions, which is not
possible using SC as these regions are dominated by the keratin
absorption [26,53]. We will explore these two options in our future
studies.
The model systems developed in this work offer a useful in vitro
alternative to excised skin to study the effects of topically applied
chemicals on the SC lipids, and thus contribute to the ongoing push to
shift the safety testing of chemicals to in vitro studies [54–56].
Importantly, they offer the possibility to mimic the modiﬁed lamellar
structure and organization of diseased SC by subtle changes of the
lipid composition; thus, they are well suited to investigate the different
impact that chemicals can have on healthy and diseased skin. The use of
such synthetic SC replacements is certainly not limited to testing the
action of fragrance materials on the lipids of the skin barrier. The
systems we present here can easily be extended to many other classes
of chemicals which may come in contact with the SC lipids, and which
can adversely modify the skin barrier properties. Thus, they can ﬁnd
broad application in the areas of product safety, healthcare, drug
delivery, and national security.
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